Dr Adam Perriman visits the House of Lords22 May 2018Dr Adam Perriman was recently treated to a special House of Lords Breakfast, which was organised by SynbiCITE, the UK's National Industrial Translation Centre for Synthetic Biology.
Business Enterprise Fellowship Award for Ben Carter18 May 2018Ben Carter has been awarded a Business Enterprise Fellowship from the Royal Society of Edinburgh to work as a business development officer in the Cellular and Molecular Medicine based spin-out company CytoSeek.
Do bacteria produce toxins to cause disease?16 May 2018The School is delighted to announce Dr Ruth Massey has been awarded a Biotechnology and Biological Sciences Research Council (BBSRC) grant to research if bacteria produce toxins to cause disease.
MRC awards CMM researcher £1.2M to investigate immune defence against microbes2 May 2018The School of Cellular and Molecular Medicine Researcher, Dr Borko Amulic, has been awarded a prestigious Career Development Award worth £1.2 million by the Medical Research Council (MRC) to lead research into how the natural ability of neutrophil immune cells can be boosted to fight infection in the post-antibiotic age.
Breakthrough in the war against viruses1 May 2018Dr Bronwen Burton from the School of Cellular and Molecular Medicine (CMM), was part of a team led by Dr Harry White from the University of Exter on a paper describing how memory B cells can adapt to target multiple strains of a virus.
Dr Ben Ede has passed his PhD viva23 March 2018Dr Ben Ede has passed his PhD viva on 22 March 2018. His thesis was titled ‘Improving treatments for T-cell Acute Lymphoblastic Leukaemia’.
MP Thangam Debbonaire visits the School 2 February 2018The School welcomed MP for Bristol West, Thangam Debbonaire on Friday 2 February, to meet with researchers and explore the Schools laboratories, where cutting-edge cancer research takes place.
Dr Nibras Khamees has passed his PhD viva31 January 2018Dr Nibras Khamees has passed his PhD viva on 30 January 2018. His thesis was entitled ‘The Role of Human Bone Marrow-Derived Mesenchymal Stem Cells in Osteomyelitis’. Nibras was co-supervised by Dr's Wael Kafienah and Darryl Hill.